- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02617797
Radiofrequency in the Female Stress Urinary Incontinence
June 21, 2023 updated by: Centro de Atenção ao Assoalho Pélvico
Radiofrequency in the Female Stress Urinary Incontinence: A Randomized Clinical Trial
Urinary stress incontinence ( SUI ) is defined as an involuntary loss of urinary Complaint no effort According to the Consensus of the International Continence Society (Society Continence International - ICS) .
SUI Prevalence of adult female Population and 25 % to 30 %.However, despite the high prevalence, many women who have symptoms of SUI or not seek treatment remain without resolution of symptoms.Then there is the possibility of using non-invasive radiofrequency and non-ablation in external urethral meatus in order to stimulate collagen production, as one of the pathophysiological mechanisms of stress urinary incontinence is the collagen deficit in the urethral wall.
It is a randomized clinical trial and the group experimental will utilize radiofrequency and kinesiotheraphy ( clinical and in home) and the group control utilize turn off- radiofrequency and kinesiotherapy (clinical and in home).
The protocol f the kinesiotherapy is the same both the group, and the protocol radiofrequency the group experimental will 5 sessions (one per week) with temperature 38ºC during 2 minutes.
The group control will 5 sessions (one per week) but the radiofrequency will off but glycerin is heated, for masking for the patient, during 2 min.
The result of the treatment is assessed by pad test 1 hour and have others outcomes ( quality of life- Sf-26 ans King Health- and sexual function- FSFI questionaire)
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Patricia V Lordelo, Phd
- Phone Number: +5571988592400
- Email: pvslordelo@hotmail.com
Study Locations
-
-
Ba
-
Salvador, Ba, Brazil, 40.290-000
- Recruiting
- Centro de Atenção ao assoalho pélvico
-
Contact:
- Cristina A Brasil, Ba
- Phone Number: +5571987929440
- Email: tinaabrasil@hotmail.com
-
Principal Investigator:
- Patricia V Lordelo, Phd
-
Contact:
- Patricia V Lordelo, Phd
- Phone Number: +5571988592400
- Email: pvslordelo@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 59 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 21 Women with age between 18-59 years old,
- women with diagnosis of urinary incontinence and have a Pelvic floor muscle contractility was assessed by digital palpation using the validated Modified Oxford Scale (MOS) greater than or equal to three
Exclusion Criteria:
- Patients with cognitive deficits or psychiatric illness;
- suffering from chronic degenerative neurological diseases; which have greater than 50 ml post-voiding residue ;
- sensory deficit in the genital region;
- people with pacemakers and implantable cardioverter-defibrillator and pregnant women will be excluded from the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Radiofrequency
Experimental group: women with urinary incontinence are subjected to standard treatment kinesiotherapy perineal ( pelvic muscle exercises ) every day in home and one session per week in the clinic in beyond the RF application in the genital area once a week to total 5 sessions.
|
The radiofrequency is a noninvasive technique that will be applied to the external urethral meatus region.It will use a digital thermometer with infrared to mention the temperature should reach 39 ° C and maintain this temperature for 2 minutes.It will use a digital thermometer with infrared to mention the temperature should reach 39 ° C and maintain this temperature for 2 minutes
|
Sham Comparator: Radiofrequency Off
Control group: women with stress urinary incontinence will be submitted to the treatment of kinesiotherapy standard perineal ( pelvic muscle exercises ) every day in home and one session per week in the clinic beyond the application of radiofrequency off in genital area once a week with the total of 5 sessions.
|
Will be used to put off radio frequency will be heated glycerin to occur masking for the patient.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Urinary loss modification
Time Frame: one week, one month, two month , three month and six month
|
The pad test will be held at the beginning of treatment and one week, one month, two month, three month and six month after the last session of radio frequency.
The pad test it quantifies in grams urinary loss through the absorbent weighing.
|
one week, one month, two month , three month and six month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
overall quality of life
Time Frame: one week
|
Will be evaluated before and after radio frequency the overall quality of life - SF-36 - questionaire.
|
one week
|
specific Quality of life
Time Frame: one week
|
The quality of life will be assessed by one for specific urinary symptoms - Health King , measure with unit of the scale
|
one week
|
Sexual Function
Time Frame: one week
|
Will be evaluated before and after radio frequency sexual function of women, through questionary FSFI in which there is a switching station which evaluates the presence of sexual dysfunction, and there is specific scores for the domains of pain, desire, lubrication, arousal, orgasm, and satisfaction.
|
one week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Patricia Lordelo, PhD, Centro de Atenção ao Assoalho Pélvico - BAHIANA
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2015
Primary Completion (Estimated)
June 1, 2024
Study Completion (Estimated)
June 1, 2025
Study Registration Dates
First Submitted
November 22, 2015
First Submitted That Met QC Criteria
November 26, 2015
First Posted (Estimated)
December 1, 2015
Study Record Updates
Last Update Posted (Actual)
June 23, 2023
Last Update Submitted That Met QC Criteria
June 21, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Behavioral Symptoms
- Mental Disorders
- Urologic Diseases
- Lower Urinary Tract Symptoms
- Urological Manifestations
- Urination Disorders
- Elimination Disorders
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Urinary Incontinence
- Enuresis
- Urinary Incontinence, Stress
Other Study ID Numbers
- U1111-1162-0945
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Stress Incontinence
-
University of New MexicoRecruitingUrinary Incontinence | Urge Incontinence | Stress Incontinence, FemaleUnited States
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
Hadassah Medical OrganizationCompletedUrinary Stress Incontinence (SI)Israel
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedUrodynamic Stress Incontinence
-
Rambam Health Care CampusCompletedStress Incontinence, FemaleIsrael
-
National Taiwan University HospitalCompletedUrodynamic Stress Incontinence
-
Aljazeera HospitalKasr El Aini HospitalUnknown
Clinical Trials on Radiofrequency OFF
-
Centro de Atenção ao Assoalho PélvicoCompletedDissatisfaction Appearance of the External Genitalia
-
Hospital General Universitario de ValenciaNot yet recruitingLow Back Pain, Recurrent | Neuropathic Pain | Mechanical Low Back Pain | Facet Joint Pain | Nociceptive Pain | Central Sensitisation | Aberrant Neuronal BranchingSpain
-
Avanos MedicalActive, not recruitingChronic Low-back PainUnited States
-
Escola Superior de Tecnologia da Saúde do PortoUniversidade Federal do Triangulo MineiroCompletedAdiposity | Abdominal ObesityBrazil
-
University of CologneUnknownSpondylolisthesis | Erosive Osteochondrosis in L2-S1Germany
-
Assiut UniversityNot yet recruitingOsteoarthritis, Knee
-
Avanos MedicalCompletedOsteoarthritis of the KneeUnited States
-
Hospital Clinic of BarcelonaActive, not recruitingQuality of Life | Chronic Pain | EndometriosisSpain
-
Assiut UniversityUnknownTrigeminal Neuralgia | Pain, Neuropathic
-
Assistance Publique - Hôpitaux de ParisTerminatedHepatocellular CancerFrance